• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OCC

ORTHOCELL LIMITED - Corporate Spotlight

6.38% ! $1.25
Market Cap $302.4M  !

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.25
Change
0.075(6.38%)
Mkt cap ! $302.4M
Open High Low Value Volume
$1.29 $1.29 $1.22 $3.277M 2.616M

Buyers (Bids)

No. Vol. Price($)
2 10721 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.26 4455 1
View Market Depth
Last trade - 16.10pm 23/04/2025 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.